timothy sykes logo
Tenet Healthcare Stock Jumps After Big Earnings Beat And Buyback Boost Thumbnail
G Google News

Tenet Healthcare Stock Jumps After Big Earnings Beat And Buyback Boost

ELLIS HOBBS•UPDATED JUL. 24, 2026, 11:34 AM ET
Reviewed by Matt Monacoand Fact-checked by Bryce Tuohey

Tenet Healthcare Corporation stocks have been trading up by 21.68 percent amid upbeat sentiment on its strengthened hospital operations.

Key Takeaways

  • Q2 2026 earnings from THC crushed expectations, with adjusted EPS at $6.12 versus $4.26 consensus and revenue at $5.63B, powered by strong same-store growth and tight cost control.
  • Management at Tenet Healthcare hiked FY26 guidance to adjusted EPS of $20.30–$21.69, lifted revenue targets to $21.9B–$22.5B, and raised EBITDA and free cash flow outlooks.
  • Shareholder returns are front and center, with an extra $2B added to THC’s buyback plan after $1.04B in repurchases last quarter, leaving $2.13B still available.
  • Wells Fargo boosted its price target on Tenet Healthcare to $231 and stayed Overweight, while BofA and Guggenheim kept Buy ratings but trimmed targets amid sector-wide hospital concerns.

Candlestick Chart

Live Update At 11:32:37 EDT: On Friday, July 24, 2026 Tenet Healthcare Corporation stock [NYSE: THC] is trending up by 21.68%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

THC is trading like a momentum leader after this latest print. The daily chart shows Tenet Healthcare ripping from a close near $199 on 2026/07/23 to about $242 on 2026/07/24, a one-day surge of more than 20%. That is the kind of range expansion active traders look for when earnings and guidance reset expectations.

Intraday, THC opened around $235 and quickly spiked to the mid-$240s, with multiple pushes toward $246.80. The 5‑minute tape shows shallow pullbacks and higher lows through the morning, a classic trend‑day pattern where dip buyers keep stepping in.

Under the hood, Tenet Healthcare is not just about the chart. Revenue runs around $21.31B, with an EBIT margin of 18.6% and EBITDA margin near 22.8%. For a hospital operator, those are stout numbers. THC posts a profit margin of roughly 7.9% and a robust return on equity north of 37%, showing the company is squeezing strong earnings out of its asset base.

More Breaking News

Valuation looks undemanding on these figures. Tenet Healthcare trades at a price‑to‑earnings ratio near 9.2 and a price‑to‑sales ratio around 0.72, while price‑to‑free‑cash flow is roughly 2.5. For traders, that combination of momentum and low multiples is exactly why THC is suddenly on so many screens.

Why Traders Are Watching THC Right Now

The latest quarter from Tenet Healthcare is the spark behind this entire move. THC delivered Q2 2026 adjusted EPS of $6.12, not only up from $4.02 a year ago but also miles ahead of the $4.26 consensus. Revenue of $5.63B beat the $5.44B estimate as same‑facility growth and stronger hospital margins did the heavy lifting. This is not a “beat by a penny” story; it is a full reset of what the market thought THC could earn.

Management backed that up with a bold outlook. Tenet Healthcare now guides FY26 adjusted EPS to $20.30–$21.69, well above prior Street consensus at $17.85. Revenue guidance moves to $21.9B–$22.5B, and adjusted EBITDA is projected about $295M higher at the midpoint. Free cash flow guidance also jumps by roughly $225M. For traders, raised guidance after a blowout quarter often extends the trend because models and expectations must catch up.

Capital returns add another kicker. THC expanded its share repurchase authorization by $2B after buying back $1.04B of stock in the last quarter alone, leaving $2.13B still available. That kind of buyback firepower can create a floor under the stock, especially during pullbacks.

Wall Street reaction lines up with the tape. Wells Fargo raised its target on Tenet Healthcare to $231 and kept an Overweight stance, pointing to improving trends in Medicare Advantage and Exchange business. BofA and Guggenheim trimmed their targets slightly but kept Buy ratings, noting broader hospital payor‑mix worries and sector multiple compression. For active traders, that mix of strong company‑specific news and cautious sector sentiment often sets up volatility — which is exactly what short‑term strategies thrive on.

Conclusion

Tenet Healthcare just checked several big boxes that momentum‑focused traders watch: a major earnings beat, a sizeable guidance raise, powerful price action, and a multi‑billion‑dollar buyback. THC has rallied from the high $180s to the mid‑$240s over a few weeks, with the post‑earnings candle standing out as a high‑volume, wide‑range breakout. That is the type of move that can attract day traders, swing traders, and longer‑term chart watchers all at once.

At the same time, the story is not risk‑free. Tenet Healthcare still operates in a sector facing payor‑mix headwinds and policy uncertainty around Medicaid. Analyst target trims from BofA and Guggenheim remind traders that hospital names can compress on valuation even while fundamentals improve. High leverage on the balance sheet also means THC must keep executing to maintain this momentum.

For those studying the move, this is a clean real‑world example of how strong fundamentals, clear guidance, and aggressive capital returns can line up with technical strength. As Tim Sykes likes to say, “The pattern is the news and the news is the pattern — when both line up, you prepare, you don’t chase.” As millionaire penny stock trader and teacher Tim Sykes, says, “Consistency is key in trading; don’t let emotions dictate your trades.”. Tenet Healthcare is now a case study in that idea, and THC will remain a key ticker for traders tracking healthcare momentum in the weeks ahead.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”